Eiger to abandon blood pressure drug after trial failure

(Reuters) - Eiger BioPharmaceuticals Inc said on Tuesday it would stop development of its drug to treat pulmonary arterial hypertension, a type of high blood pressure, after it failed in a mid-stage study.

Source: Reuters: Health - January 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news